Latest "Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner" News Stories

11:30 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner" found in our extensive news archives from over 250 global news sources.

More Information about Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner for you to read. Along with our medical data and news we also list Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner Clinical Trials, which are updated daily. BioPortfolio also has a large database of Clinical Trial Protocol for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids in a 3T MRI Scanner Companies for you to search.

Showing "Clinical Trial Protocol Therapeutic guided High Intensity Focused" News Articles 1–25 of 33,000+

Tuesday 13th November 2018

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

Construction Begins on Orthopaedic Institute for Children’s New Medical Pavilion Reimagining Pediatric Care in the 21st Century

Construction has begun on the new medical pavilion at Orthopaedic Institute for Children, the centerpiece of the hospital’s “Vision for Our Future” campaign, which will ensure that OIC’s surgeons, doctors and nurses have the best facilities and equipment to care for the increasing number of children who come through its doors. The new medi...

Type 2 Diabetes and Liver Disease: Twin Epidemics Call for Early Detection, Monitoring and Lifestyle Changes -- Echosens Advises Americans “Know Your Risk”

November 2018 American Diabetes Month Echosens, an innovative high-technology company offering the FibroScan family of products, points to the inextricable, well-documented links between asymptomatic non-alcoholic fatty li

Verisante Technology Inc Product Pipeline Analysis, 2018 Update [Report Updated: 25102018] Prices from USD $750

SummaryVerisante Technology Inc Verisante is a medical device company that develops and commercializes systems for the early detection of cancer. The company's key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a...

AxoGen Inc AXGN Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryAxoGen Inc AxoGen, formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch twopoint discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among others. It also offers clinical research studies in understanding and outcome of peripheral nerve regen...

24Hr HomeCare Named Number 81 on the Los Angeles Business Journal Fastest Growing Private Companies List for the Sixth Consecutive Year!

24Hr HomeCare is elated to announce that they have been named number 81 on the Los Angeles Business Journal’s List of Fastest Growing Companies for the sixth consecutive year. This award comes on the heels of 24Hr HomeCare, who celebrated their 10th anniversary this past year, being named on Inc. 5000 list for a sixth consecutive year as well! T...

High-#Protein Diet Exposes #Cancer Stem Cells to New Drug Approach:

High- #Protein Diet Exposes #Cancer Stem Cells to New Drug Approach:

Healthcare Marketing Agency Launches A New Site To Scale & Expand Patient Growth for Medical Practices & Healthcare Professionals

Intrepy Healthcare Marketing has launched a new website for physicians, hospitals, dentists, and healthcare experts who want to learn more about the robust and constantly evolving healthcare marketing industry. The site offers a hands-on approach to training and information on implementing healthcare marketing initiatives that increase patient growth for medical & dental practices of all sizes...

Grupo Meridional Announces Acquisition of Hospital Metropolitano

H.I.G. Capital, LLC ("H.I.G."), a leading global private equity investment firm with $30 billion of equity capital under management, is pleased to announce that its portfolio company, Grupo Meridional (“Meridional” or the “Group”), one of the leading hospital groups in Brazil, has acquired Hospital Metropolitano (“Metropolitano”). ...

Computer Chips Cool Down with Laser Metal Printing

NewsThe design will save energy and reduce toxic electronic waste — welcome news for data centers, gamers, and anyone with high-end electronics.Contri

Life Image and Dicom Systems Partner to Advance Healthcare Interoperability

Life Image Network with Advanced Data Sharing and Dicom Systems’ Internal Integration Expertise Combine to Automate Interoperability Within and Among Organizations Across the Healthcare Ecosystem Life Image, the world's largest global network for sharing clinical and imaging data, and

The Verdict on IMRT Plus Doxorubicin in Unresectable Thyroid Cancer

A study in Thyroid evaluated the safety and efficacy of concurrent intensity-modulated radiation therapy and doxorubicin in thyroid cancer.

Black students who have one black teacher are more likely to go to college

Beneficial Gut Bacteria Metabolize Fiber to Improve Heart Health

NewsA fatty acid has been identified as the mechanism behind protective effects of a high-fiber diet in a mouse model, supporting the microbial connection between fiber and heart health.

Wolters Kluwer Helps Mercy Ships Provide Healing and State-of-the-Art Care for the World’s Poor

Mercy Ships clinicians aboard their floating hospital ship, the Africa Mercy, care for the world’s most vulnerable populations. The ship is currently on a nearly year-long mission in the west African country of Guinea, providing free lifesaving surgeries in a region where medical care is very limited. To support Mercy Ships,

Wide Range of Presentations at Fasano Longevity Conference

The November 5th Fasano Longevity Conference included a wide range of presentations, including an analysis of the mid-term elections and groundbreaking cancer research. Washington insider, Kevin Madden, opened the Conference with his take on the mid-term elections. He was followed by Coventry Chairman, Alan Buerger, who gave an upbeat assessment o...

Michael J. Dowling, President and CEO of Northwell Health, Named Innovator of the Year by Press Ganey

Press Ganey today honored Michael J. Dowling, President and CEO of Northwell Health, with its 2018 Innovator of the Year Award. The award was presented by Press Ganey CEO Patrick Ryan at the organization’s annual National Client Conference in Orlando, Florida, in front of an audience of more than 3,000 health care professionals. The Innov...

Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System

Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease DUBLIN - November 13, 2018 - Medtronic plc (NYSE:MDT) today announced it has received CE Mark approval for the Valiant Navion(TM) thoracic stent graft system for the minimally invasive repair of all lesions of the descending thoracic aorta, including...

United Derm Partners Announces Continued Expansion of Skin Cancer & Dermatology Institute in Northern Nevada

Addition of Sierra Skin Institute Strengthens General and Cosmetic Dermatologic Services to Reno and Northern Nevada Regions United Derm Partners, a physician services organization focused on the dermatology sector, today announced the continued expansion of Skin Cancer

Generex Publishes Update to Pending 20:1 Stock Dividend

Generex Biotechnology Corporation ( (OTCQB:GNBT) ( today released an update on its previously announced 20:1 common stock dividend pending completion of FINRA review. All OTC traded companies are required to file a notice with FINRA of material corporate

Bay Labs and Northwestern Medicine Enroll First Patient in Study Using AI Software to Improve Heart Disease Detection

Clinical Trial Evaluates if AI Helps Certified Medical Assistants Perform Echocardiograms and Detect Heart Disease in Primary Care Settings Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, and

Vernalis Research, a Ligand Company, Achieves Success Milestones in Collaboration with Daiichi Sankyo

Vernalis Research, a Ligand Company, announced today that it has earned multiple success milestones under its drug discovery collaboration with Daiichi Sankyo Company, Limited (Daiichi Sankyo) that began in December of 2017. The research utilizes Vernalis' fragment and structure-based drug discovery platform for two undisclosed oncology targets. A...

1CellBio and the Open Medicine Institute Join Forces to Demonstrate Power of Single-Cell RNA Sequencing in Precision Medicine Applications

inDrop™ System selected to generate predictive multi-omic clinical research data for undiagnosed conditions with immune dysfunction 1CellBio Inc., a leading single-cell analysis company serving the biomedical research community, today announced a partnership agreement with the Open Medicine Institute (OMI), a leading independent precision medicine cl...

ImmunoRestoration, Inc. Announces IND Transfer Completed

HER-2 Pulsed DC Vaccine ImmunoRestoration, Inc., a biotech recently formed to lead the development and commercialization of a novel immunotherapeutic cancer cell therapy platform, announces the receipt of the previously held Investigator IND, BB-IND-11043 from Dr. Brian Czerniecki, MD., Ph.D, of the H. Lee Moffitt Cancer Center & Research Institute...

Quick Search


News Quicklinks